Read + Share
Su J, Hu W, Ding Y, Zhang P, et al. Serum GM-CSF level is a predictor of treatment response to tocilizumab in
rheumatoid arthritis patients: a prospective observational cohort study. Arthritis Res Ther 2024;26:130.
PMID: 38997725
|
 |
|
Su J, Hu W, Ding Y, Zhang P, et al. Serum GM-CSF level is a predictor of treatment response to tocilizumab in
rheumatoid arthritis patients: a prospective observational cohort study. Arthritis Res Ther 2024;26:130.
PMID: 38997725
|
|
|
|